Daily Reporter

Latest News
In the Spotlight
Opinions
Columns
About

ESMO events

Refine search

Date

Any time

This month

This year

Before this year

Tumour Site

Breast Cancer
Carcinoma of Unknown Primary Site (CUP)
Central Nervous System Malignancies
Endocrine Tumours
- Adrenal Carcinoma
- Neuroendocrine Neoplasms
- Thyroid Cancer
Gastrointestinal Cancers
- Anal Cancer
- Colon and Rectal Cancer
- Gastric Cancer
- Gastro-Oesophageal Junction Cancer
- Hepatobiliary Cancers
- Oesophageal Cancer
- Pancreatic Adenocarcinoma
Genitourinary Cancers
- Malignant Germ-Cell Tumours of the Adult Male
- Penile Cancer
- Prostate Cancer
- Renal Cell Cancer
- Urothelial Cancer
Gynaecological Malignancies
- Cervical Cancer
- Endometrial Cancer
- Gestational Trophoblastic Neoplasia
- Ovarian Cancer
- Vulvar and Vaginal Cancers
Haematological Malignancies
- Leukaemias
  - Acute Lymphoblastic Leukaemia
  - Acute Myeloid Leukaemia
  - Chronic Lymphocytic Leukaemia
  - Chronic Myeloid Leukaemia
  - Hairy Cell Leukaemia
- Lymphomas
  - Follicular Lymphoma
  - Hodgkin Lymphoma
  - Large B-Cell Lymphoma
  - Mantle Cell Lymphoma
  - Marginal Zone Lymphoma
  - Peripheral T-Cell Lymphoma
  - Primary Cutaneous Lymphoma
- MDS/MPN/Others
- Multiple Myeloma
Head and Neck Cancers
Sarcoma
- Bone Sarcomas
- GIST
- Soft Tissue Sarcomas
Skin Cancers
- Basal Cell and Squamous Cell Cancers of the Skin
- Melanoma
- Merkel Cell Carcinoma
Thoracic Malignancies
- Mesothelioma
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Thymoma and Thymic Cancer

Topics

Basic Science
- Cancer Biology
- Molecular Oncology
- Tumour Immunology
Cancer Control Principles
- Cancer Care Equity Principles and Health Economics
- Cancer Intelligence (eHealth, Telehealth Technology, BIG Data)
- Fundamentals of Cancer Care Organisation
- Global Cancer Control
- Multi-Disciplinary and Multi-Professional Cancer Care
Cancer Diagnostics
- Genetic and Genomic Testing
- Laboratory Diagnostics
- Pathology/Molecular Biology
Cancer Epidemiology
- Cancer Registries
- Global Cancer Statistics
Cancer in Special Situations/ Populations
- AIDS-Associated Malignancies
- Cancer and Pregnancy
- Cancer in Adolescents and Young Adults (AYA)
- Cancer in LGBTQ Populations
- Cancer in Older Adults
- Cancer Treatment in Patients with Comorbidities
- COVID-19 and Cancer
Cancer Prevention
- Population Risk Factor
- Primary Prevention
- Secondary Prevention/Screening
Cancer Research
- Bioethical Principles and GCP
- Clinical Research
- Statistics
- Translational Research
Career Development
Emergency in Oncology
Genetic Testing and Counselling
Psychosocial Aspects of Cancer
- Communication Skills
- Patient Education and Advocacy
- Psycho-Oncology
Rare Cancers
Staging and Imaging
- Nuclear Medicine and Clinical Molecular Imaging
- Radiological Imaging
- Response Evaluation (RECIST Criteria)
- Staging Procedures
Supportive and Palliative Care
- End-of-Life Care
- Management of Systemic Therapy Toxicities
- Nutritional Support
- Supportive Care and Symptom Management
Survivorship
Therapy
- Cell-Based Therapy
- Cytotoxic Therapy
- Endocrine Therapy
- Image-Guided Therapy
- Immunotherapy
- Radiation Oncology
- Surgical Oncology
- Targeted Therapy

Congress

All congresses
ESMO Congress 2023
ESMO Asia Congress 2023
ESMO Immuno-Oncology Congress 2023
ESMO Targeted Anticancer Therapies Congress 2024
ESMO Sarcoma and Rare Cancers Congress 2024
European Lung Cancer Congress 2024
ESMO Breast Cancer 2024
ESMO Gynaecological Cancers Congress 2024
ESMO Gastrointestinal Cancers Congress 2024
ESMO Congress 2024
Molecular Analysis for Precision Oncology Congress (MAP) 2024
ESMO Asia Congress 2024
ESMO Immuno-Oncology Congress 2024
Molecular Analysis for Precision Oncology Congress (MAP) 2023
ESMO Breast Cancer 2023
ESMO Sarcoma and Rare Cancers Congress 2023
European Lung Cancer Congress 2023
ESMO Targeted Anticancer Therapies Congress 2023
ESMO Gynaecological Cancers Congress 2023
ESMO Asia Congress 2022
ESMO Immuno-Oncology Congress 2022
Molecular Analysis for Precision Oncology Congress 2022
ESMO Congress 2022
ESMO Gynaecological Cancers Congress 2022
ESMO Breast Cancer 2022

Clear all

All filters

693 results for ""

Sort by

RAS: a moving target

29 Sept 2019

To escalate or de-escalate? The question in HER2-positive breast cancer (1)

29 Sept 2019

Machine learning in oncology: the future is (almost) here

29 Sept 2019

To escalate or de-escalate? The question in HER2-positive breast cancer (2)

29 Sept 2019

Is it time to go beyond randomisation of clinical trials? (2)

28 Sept 2019

Ipilumab plus nivolumab shows efficacy in resected stage IV melanoma

28 Sept 2019

NSCLC: challenges of a common cancer split into subgroups

28 Sept 2019

FLAURA trial: overall survival results confirms the efficacy of osimertinib in the treatment of NSCLC

28 Sept 2019

Thoracic Malignancies

Anlotinib improves overall survival in relapsed SCLC

Results of ALTER 1202 reveal survival benefit for anlotinib third-line in small-cell lung cancer

28 Sept 2019

Gynaecological Malignancies

Cediranib–olaparib combination is effective regardless of disease mutations

Results from the BAROCCO trial may help define the optimum treatment schedule for an antiangiogenic–PARP inhibitor combination in recurrent, platinum-resistant ovarian cancer

28 Sept 2019

1
...
60
61
62
63
64
65
66
67 of 70
68
69
70

Legal

Change cookie settings

Useful links

About ESMO
Contact Us

Get our news straight to your box

Subscribe to the ESMO Daily Reporter Alert and find out the latest advances in cancer care with our news and interviews to international experts. To receive the alert on a regular basis, create or login to your ESMO account and opt-in.

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
© Copyright 2024 European Society for Medical Oncology All rights reserved worldwide.

Twitter
Facebook
Youtube
RSS
LinkedIn
Instagram